Skip to content
value.today

Medical Simulation Corp.

Total raised
$20 M
3 rounds on record
Latest round
$3 M
Nov 2015
First round on record
Apr 2012
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Medical Simulation Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2015$3 MNo. 3$2 to $10 million

Medical Simulation Corp.: Raise no. 3, Nov 2015

Investors in this round

7 investors had bought by the notice of Dec 8, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mary Beth Loesch · Executive Officer, Director
  • Robert W. Vidal · Executive Officer
  • Henri W. Termeer · Director
  • James Beth Tobin · Director
  • James W. Hirschmann III · Director
  • John W. Gaither · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total amount sold includes the conversion of $762,444 of debt.”

Signed by Mary Beth Loesch, President and CEO. Source: SEC Form D, newest notice filed Dec 8, 2015. Read the notice at the SEC.

equitySEC
Jul 2013$14 MNo. 2$10 to $50 million

Medical Simulation Corp.: Raise no. 2, Jul 2013

Investors in this round

16 investors had bought by the notice of Aug 27, 2013: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
$1,474
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alan E. Armer · Executive Officer · Vice President and COO
  • David E. McKenzie · Executive Officer · Vice President of Finance
  • Sandra E. Schreiber · Executive Officer · Senior Vice President and Secretary
  • William E. Younkes · Executive Officer, Director · President and CEO
  • Frederic E. Hamilton · Director
  • Henri E. Termeer · Director
  • James W. Hirschmann III · Director
  • James W. Tobin · Director
  • John W. Gaither, Jr. · Director
  • Mark W. Kozin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “"Offer and sale of Series F Conv. Pref. Stock (""Series F""); conversion of Notes into Series F and Common Stock; issuance of Promissory Note; and Warrants to Purchase Series F and the Series F thereunder"”

Signed by David McKenzie, Vice President of Finance. Source: SEC Form D and 1 amendment, newest notice filed Aug 27, 2013. Read the notice at the SEC.

equity, debt, optionsSEC
Apr 2012$3 MNo. 1$2 to $10 million

Medical Simulation Corp.: Raise no. 1, Apr 2012

Investors in this round

5 investors had bought by the notice of Apr 25, 2012: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$450,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bill Younkes · Executive Officer, Director
  • David McKenzie · Executive Officer
  • Sandi Schreiber · Executive Officer
  • Frederic C. Hamilton, Jr. · Director
  • Henri C. Termeer · Director
  • James C. Hirschmann, III · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “$250,000 is estimated for deferred compensation payments and $200,000 is estimated for serverance and vacation payments all to be made in the ordinary course of business for existing obligations unrelated to this financing.”

Signed by David McKenzie, VP - Finance. Source: SEC Form D, newest notice filed Apr 25, 2012. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Medical Simulation Corp. chose not to state its revenue in its newest notice of a funding round (Dec 2015).

    SEC Form D · Dec 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2015

That is all the official record says: Medical Simulation Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Medical Simulation Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 16 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Medical Simulation Corp.
NameRoleNamed in
Mary Beth LoeschExecutive officerDec 2015
Robert W. VidalExecutive officerDec 2015
Alan E. ArmerVice President and COOAug 2013
David E. McKenzieVice President of FinanceAug 2013
Sandra E. SchreiberSenior Vice President and SecretaryAug 2013
William E. YounkesPresident and CEOAug 2013
Bill YounkesExecutive officerApr 2012
David McKenzieExecutive officerApr 2012
Sandi SchreiberExecutive officerApr 2012
Henri W. TermeerDirectorDec 2015
James Beth TobinDirectorDec 2015
James W. Hirschmann IIIDirectorDec 2015
John W. GaitherDirectorDec 2015
Mary Beth LoeschDirectorDec 2015
Frederic E. HamiltonDirectorAug 2013
Henri E. TermeerDirectorAug 2013
James W. TobinDirectorAug 2013
John W. Gaither, Jr.DirectorAug 2013
Mark W. KozinDirectorAug 2013
William E. YounkesPresident and CEOAug 2013
Bill YounkesDirectorApr 2012
Frederic C. Hamilton, Jr.DirectorApr 2012
Henri C. TermeerDirectorApr 2012
James C. Hirschmann, IIIDirectorApr 2012